Form D — ReEngage Therapeutics, Inc.
0002022524-25-000002 · filed 2025-06-18
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $8,000,000
- Total sold
- $250,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ReEngage Therapeutics, Inc.
- CIK
- 2022524
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 2450 HOLCOMBE BLVD. SUITE 1200
HOUSTON, TX 77021 - Phone
- 215-400-0133
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thomas Kim · Executive OfficerHouston, TX Find on LinkedIn ↗
View original on SEC EDGAR.